Neurology Today
Joseph E. Safdieh, MD, FAAN, Editor-in-Chief of Neurology Today provides an overview of topics covered in the latest issue.
ME/CFS and long COVID; negative outcomes for ALS drug; donanemab
BTK inhibitors for MS, lecanemab, neurologic adverse effects and COVID vaccine
SARS-CoV-2 and dopamine neurons, valproate risks for men, neurologists on locum tenens
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More